Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dorland Sweeney Jones was a Philadelphia-based healthcare communications and medical marketing agency serving pharmaceutical and healthcare clients. The firm appears to have operated under the Dorland Sweeney Jones name before later being referred to as Dorland Global, with business lines including health communications and public relations. In 2007, Dorland Global was acquired by Huntsworth PLC for about $20.7 million, after which it became part of Huntsworth Health's U.S. operations. Based on available evidence, this was not a drug-development biotech or pharma manufacturer, but a health-focused services company supporting commercial, branding, advertising, and communications needs in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dorland Global.